EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.